Literature DB >> 19091815

In vivo and in vitro alterations in influenza A/H3N2 virus M2 and hemagglutinin genes: effect of passage in MDCK-SIAT1 cells and conventional MDCK cells.

Danjuan Li1, Reiko Saito, Yasushi Suzuki, Isamu Sato, Hassan Zaraket, Clyde Dapat, Isolde Ma Caperig-Dapat, Hiroshi Suzuki.   

Abstract

No mutations were detected in the hemagglutinin gene of influenza A/H3N2 virus isolates from patients undergoing short-term amantadine treatment. However, genetic changes occurred after serial passage in either MDCK or MDCK-SIAT1 cells. Our results showed that only a few mutations were observed in MDCK-SIAT1-passaged isolates in the presence of amantadine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091815      PMCID: PMC2643669          DOI: 10.1128/JCM.00892-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan.

Authors:  H Masuda; H Suzuki; H Oshitani; R Saito; S Kawasaki; M Nishikawa; H Satoh
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

2.  Amantadine-resistant influenza A (H3N2) virus in Japan, 2005-2006.

Authors:  Reiko Saito; Danjuan Li; Hiroshi Suzuki
Journal:  N Engl J Med       Date:  2007-01-18       Impact factor: 91.245

3.  Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection.

Authors:  T Ito; Y Suzuki; A Takada; A Kawamoto; K Otsuki; H Masuda; M Yamada; T Suzuki; H Kida; Y Kawaoka
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  Universal primer set for the full-length amplification of all influenza A viruses.

Authors:  E Hoffmann; J Stech; Y Guan; R G Webster; D R Perez
Journal:  Arch Virol       Date:  2001-12       Impact factor: 2.574

5.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid.

Authors:  W Weis; J H Brown; S Cusack; J C Paulson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

6.  Influenza A virus M2 ion channel protein: a structure-function analysis.

Authors:  L J Holsinger; D Nichani; L H Pinto; R A Lamb
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors.

Authors:  Mikhail Matrosovich; Tatyana Matrosovich; Jackie Carr; Noel A Roberts; Hans-Dieter Klenk
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses.

Authors:  E P Rocha; X Xu; H E Hall; J R Allen; H L Regnery; N J Cox
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

9.  Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use.

Authors:  P Houck; M Hemphill; S LaCroix; D Hirsh; N Cox
Journal:  Arch Intern Med       Date:  1995-03-13

10.  Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States.

Authors:  Martha I Nelson; Laurel Edelman; David J Spiro; Alex R Boyne; Jayati Bera; Rebecca Halpin; Naomi Sengamalay; Elodie Ghedin; Mark A Miller; Lone Simonsen; Cecile Viboud; Edward C Holmes
Journal:  PLoS Pathog       Date:  2008-08-22       Impact factor: 6.823

View more
  7 in total

1.  Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infections.

Authors:  Yongli Xiao; Jae-Keun Park; Stephanie Williams; Mitchell Ramuta; Adriana Cervantes-Medina; Tyler Bristol; Sarah Smith; Lindsay Czajkowski; Alison Han; John C Kash; Matthew J Memoli; Jeffery K Taubenberger
Journal:  Virology       Date:  2019-06-13       Impact factor: 3.616

2.  The matrix gene of influenza A H5N1 in Egypt, 2006-2016: molecular insights and distribution of amantadine-resistant variants.

Authors:  Mahmoud M Naguib; Naglaa Hagag; Ahmed A El-Sanousi; Hussein Ali Hussein; Abdel-Satar Arafa
Journal:  Virus Genes       Date:  2016-07-23       Impact factor: 2.332

3.  Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.

Authors:  Jun Wang; Chunlong Ma; Giacomo Fiorin; Vincenzo Carnevale; Tuo Wang; Fanghao Hu; Robert A Lamb; Lawrence H Pinto; Mei Hong; Michael L Klein; William F DeGrado
Journal:  J Am Chem Soc       Date:  2011-07-21       Impact factor: 15.419

4.  Enhancing the yield of seasonal influenza viruses through manipulation of microRNAs in Madin-Darby canine kidney cells.

Authors:  Suthat Saengchoowong; Pattaraporn Nimsamer; Kritsada Khongnomnan; Witthaya Poomipak; Kesmanee Praianantathavorn; Somruthai Rattanaburi; Yong Poovorawan; Qibo Zhang; Sunchai Payungporn
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

5.  Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.

Authors:  Victoria Balannik; Jun Wang; Yuki Ohigashi; Xianghong Jing; Emma Magavern; Robert A Lamb; William F Degrado; Lawrence H Pinto
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

6.  Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or Spread.

Authors:  Shelly Gulati; David F Smith; Richard D Cummings; Robert B Couch; Sara B Griesemer; Kirsten St George; Robert G Webster; Gillian M Air
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

7.  Comparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passage.

Authors:  Hong Kai Lee; Julian Wei-Tze Tang; Debra Han-Lin Kong; Tze Ping Loh; Donald Kok-Leong Chiang; Tommy Tsan-Yuk Lam; Evelyn Siew-Chuan Koay
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.